Professor, Department of Pharmacy,
BITS Pilani, Pilani Campus
Sr. No. | Title of the project | Role | Sanction No. | Funding Agency | Duration | Funds sanctioned (Rs., Lakh) |
1 | Design and Synthesis of Novel Agents for the Management of Rheumatoid Arthritis | PI | 37-117/2009 (SR) | University Grants Commission | 1/4/2010-31/3/2013 | 8.35 |
2 | Design and Synthesis of Novel Agents for the Treatment of Rheumatoid Arthritis | PI | SR/FT/CS-100/2009 | Department of Science and Technology | 1/9/2010-31/8/2013 | 19.03 |
3 | Analysis of herbal extracts and formulations for antioxidant activity | PI |
| Vedic Life Sciences, Mumbai, India | 2006-07 | 0.5 |
4 | Verifying the structural evidence for the presence of Sennosides | PI |
| Shashi Phytochemicals Limited, India | 2012 | 0.5 |
5 | Design, synthesis, and biological evaluations of b- secretase inhibitors as anti-Alzheimer's agents | Co-PI | DST/INT/Pol/P-21/2016 | DST Indo-Polish Joint Research Programme. Project No. DST/INT/Pol/P-21/2016. Indian PI: Dr. Ruchi Malik, Central Univ of Rajasthan and Polish PI: Prof. Slawomir Filipek, University of Warsaw, Warsaw, Poland | 7/6/2017-6/6/2020 | 19.84 |
6 | DBT-BUILDER -University of Birla Institute of Technology and Science Pilani, Pilani Campus: Interdisciplinary Life Science Programme for Advanced Research and Education in Epigenetics and Genome Editing | Co-PI | BT/INF/22/SP42545/2021 | Department of Biotechnology | 24/9/2021-23/9/2026 | 901.8 |
7 | Design, synthesis, and evaluation of novel dual inhibitors of Angiotensin-II type 1 receptor and Neprilysin for the treatment of diabetic cardiomyopathy | PI | CRG/2022/004698 | Science and Engineering Research Board | 07/11/2023- 06/11/2026 | 33.02 |
8 | Design, synthesis, and evaluation of novel dual inhibitors of dipeptidyl peptidase 4 (DPPIV) and Neprilysin for the treatment of diabetes | PI | IIRP-2023-6880 | ICMR | Sanctioned | 30.06 |